New Classifications of Five Distinct “Sleep” Profi... ...
Science in the Age of AI | AI for Science Forum...
Ask the Heart Doctor | Heart Valve Disease and Sur...
High-speed imaging tracks live brain cell activity...
NAD⁺ restores memory in Alzheimer's disease models...
Mark Cuban: A Master Disrupter for American Health...
Teen girls facing the most adversity showed the biggest gain...
September 15,2026
Specialized imaging reveals hormone-driven brain changes...
September 14,2026
Submillimeter MRI reveals brain hubs that guide risky decisi...
September 12,2026
Risk of herpes zoster among breast cancer survivors in Japan...
September 11,2026
Three proteins help organs tailor shared circadian clock to ...
September 10,2026
Should you worry about melatonin and heart failure? The evid...
December 02,2025
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
GOSH BRC Showcase 2025 - Genomic medicine...
Can a twice-a-year shot help end the HIV...
Announcement of the 2025 Nobel Prize in ...
Reprogramming Stem Cells Could Cure Type...
Why MDMA did NOT get FDA approval...
More News
Researchers develop a small molecule that could make immunotherapy available to all cancer patients

Researchers develop a small molecule that could make immunotherapy available to all cancer patients

byTel-Aviv UniversityCredit: CC0 Public DomainResearchers at Tel Aviv University and the University of Lisbon have jointly identified and synthesized a small molecule that could be a more access
World medicine December 16,2023
Researchers develop a small molecule that could make immunotherapy available to all cancer patients

Researchers develop a small molecule that could make immunotherapy available to all cancer patients

byTel-Aviv UniversityCredit: CC0 Public DomainResearchers at Tel Aviv University and the University of Lisbon have jointly identified and synthesized a small molecule that could be a more access
World medicine December 16,2023
FLASH radiation therapy shows promise in first-in-human trial

FLASH radiation therapy shows promise in first-in-human trial

byAmerican Society for Radiation OncologyCredit: Unsplash/CC0 Public DomainFLASH radiation treatment—which delivers therapeutic doses of radiation in a fraction of a second—may hold promise as a
World medicine December 16,2023
FLASH radiation therapy shows promise in first-in-human trial

FLASH radiation therapy shows promise in first-in-human trial

byAmerican Society for Radiation OncologyCredit: Unsplash/CC0 Public DomainFLASH radiation treatment—which delivers therapeutic doses of radiation in a fraction of a second—may hold promise as a
World medicine December 16,2023
Pathogenic germline variants identified in patients with lung cancer

Pathogenic germline variants identified in patients with lung cancer

A total of 14.9 percent of patients with lung cancer have pathogenic germline variants (PGV), most of which are potentially clinically actionable, according to a study presented Aug. 16 as part of the
World medicine December 16,2023
Pathogenic germline variants identified in patients with lung cancer

Pathogenic germline variants identified in patients with lung cancer

A total of 14.9 percent of patients with lung cancer have pathogenic germline variants (PGV), most of which are potentially clinically actionable, according to a study presented Aug. 16 as part of the
World medicine December 16,2023
'Inside out' signaling promotes tumor growth

'Inside out' signaling promotes tumor growth

by Will Doss,Northwestern UniversityPharmacological inhibitor of MLCK MW01-022AZ suppressed tumor inflammation and growth. a Schematic of LLC lung tumor implantation in C57Bl6 mice and MW01-022A
World medicine December 16,2023
'Inside out' signaling promotes tumor growth

'Inside out' signaling promotes tumor growth

by Will Doss,Northwestern UniversityPharmacological inhibitor of MLCK MW01-022AZ suppressed tumor inflammation and growth. a Schematic of LLC lung tumor implantation in C57Bl6 mice and MW01-022A
World medicine December 16,2023
New chip could make treating metastatic cancer easier and faster

New chip could make treating metastatic cancer easier and faster

byGeorgia Institute of TechnologyFabrication of the microchip. The device is fabricated by injecting a polymer into a micro fabricated mold and the polymer is cured under ultraviolet light to pr
World medicine December 16,2023
New chip could make treating metastatic cancer easier and faster

New chip could make treating metastatic cancer easier and faster

byGeorgia Institute of TechnologyFabrication of the microchip. The device is fabricated by injecting a polymer into a micro fabricated mold and the polymer is cured under ultraviolet light to pr
World medicine December 16,2023
Considering genetic risk in prostate cancer referrals could lead to earlier diagnosis

Considering genetic risk in prostate cancer referrals could lead to earlier diagnosis

byUniversity of ExeterCredit: Pixabay/CC0 Public DomainMen at the highest risk for prostate cancer could be fast-tracked for investigation if their genetic risk was considered in general practic
World medicine December 16,2023
Considering genetic risk in prostate cancer referrals could lead to earlier diagnosis

Considering genetic risk in prostate cancer referrals could lead to earlier diagnosis

byUniversity of ExeterCredit: Pixabay/CC0 Public DomainMen at the highest risk for prostate cancer could be fast-tracked for investigation if their genetic risk was considered in general practic
World medicine December 16,2023
Researchers study rare genetic condition to tackle colorectal cancer

Researchers study rare genetic condition to tackle colorectal cancer

by Joe Dangor,Mayo ClinicCancer—Histopathologic image of colonic carcinoid. Credit: Wikipedia/CC BY-SA 3.0Researchers from the Mayo Clinic Comprehensive Cancer Center and the Mayo Clinic Center
World medicine December 16,2023
Researchers study rare genetic condition to tackle colorectal cancer

Researchers study rare genetic condition to tackle colorectal cancer

by Joe Dangor,Mayo ClinicCancer—Histopathologic image of colonic carcinoid. Credit: Wikipedia/CC BY-SA 3.0Researchers from the Mayo Clinic Comprehensive Cancer Center and the Mayo Clinic Center
World medicine December 16,2023
FDA approves new drug for chronic lymphocytic leukemia, small lymphocytic lymphoma

FDA approves new drug for chronic lymphocytic leukemia, small lymphocytic lymphoma

by Lori SolomonThe U.S. Food and Drug Administration hasapprovedzanubrutinib (Brukinsa), a next-generation BTK inhibitor, for the treatment of patients with chronic lymphocytic leukemia or
World medicine December 16,2023
FDA approves new drug for chronic lymphocytic leukemia, small lymphocytic lymphoma

FDA approves new drug for chronic lymphocytic leukemia, small lymphocytic lymphoma

by Lori SolomonThe U.S. Food and Drug Administration hasapprovedzanubrutinib (Brukinsa), a next-generation BTK inhibitor, for the treatment of patients with chronic lymphocytic leukemia or
World medicine December 16,2023
Starting colonoscopy every 10 years at age 45 cost-effective for all

Starting colonoscopy every 10 years at age 45 cost-effective for all

Initiating colonoscopy every 10 years (Colo10) at age 45 years or an annual fecal immunochemical test (FIT) at 40 years is cost-effective for all body mass index (BMI) and sex groups, according to a s
World medicine December 16,2023
Starting colonoscopy every 10 years at age 45 cost-effective for all

Starting colonoscopy every 10 years at age 45 cost-effective for all

Initiating colonoscopy every 10 years (Colo10) at age 45 years or an annual fecal immunochemical test (FIT) at 40 years is cost-effective for all body mass index (BMI) and sex groups, according to a s
World medicine December 16,2023
FDA approves gene therapy for tough-to-treat bladder cancer

FDA approves gene therapy for tough-to-treat bladder cancer

by Cara Murez HealthDay ReporterPatients with a high-risk bladder cancer now have a new option to treat it.The U.S. Food and Drug Administration has approved agene therapycalled Adstiladri
World medicine December 16,2023
FDA approves gene therapy for tough-to-treat bladder cancer

FDA approves gene therapy for tough-to-treat bladder cancer

by Cara Murez HealthDay ReporterPatients with a high-risk bladder cancer now have a new option to treat it.The U.S. Food and Drug Administration has approved agene therapycalled Adstiladri
World medicine December 16,2023
More News
Week’s Top
Podcasts
... Health spending has been rising across rich countries with different systems ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com